Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation–associated metastatic renal-cell carcinoma
2018 ◽
Vol 11
(4)
◽
pp. 962-970
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 27
(7)
◽
pp. 804-811
◽